HLB shares rose 17% after an FDA inspection of its liver cancer drug plant closed as VAI, clearing the way for a refiling.
Following the major Cyclospora outbreak linked to iceberg lettuce, consumers might assume that produce labeled "triple-washed ...
SEVEN different types of cancer are increasing in Brits under 50, new research shows. And it’s not just bowel cancer – rates ...
HLB said the FDA classified rivoceranib's finished-drug plant as VAI, easing manufacturing concerns ahead of an NDA ...
Galectin Therapeutics and its associated logo is a registered trademark of Galectin Therapeutics Inc. Belapectin is the USAN assigned name for Galectin Therapeutics’ galectin-3 inhibitor belapectin.
Organic foods seem good for the body, but are they effective for dieting?Organic foods have an image of being gentle on the body, but "Do I lose weight just by eating them?""How are they different ...
Most people walk out of the pharmacy expecting two warnings: don't drink on this, and check before you add a supplement. Both ...
HLB shares surged 23 percent on the KOSDAQ after its U.S. subsidiary confirmed that the FDA had cleared the final manufacturing facility tied to ...
With fatty liver disease becoming increasingly common, health experts have warned that the growing burden of the condition could translate into a significant rise in advanced liver disease and liver ...
A machine learning analysis of more than 8,400 Canadian adults with MASLD shows that mortality risk predictors differ sharply ...
In 2015, a new class of cholesterol-lowering injectable drugs called PCSK9-inhibitors was approved by the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results